PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role of the spliceosome component PRPF8 (pre-mRNA processing factor 8) in HCC. PRPF8 expression (mRNA/protein) was analyzed in a retrospective cohort of HCC patients (n = 172 HCC and nontumor tissues) and validated in two in silico cohorts (TCGA and CPTAC). PRPF8 expression was silenced in liver cancer cell lines and in xenograft tumors to understand the functional and mechanistic consequences. In silico RNAseq and CLIPseq data were also analyzed. Our results indicate that PRPF8 is overexpressed in HCC and associated with increased tumor aggressiveness (patient survival, etc.), expression of HCC-related splice variants, and modulation of critical genes implicated in cancer-related pathways. PRPF8 silencing ameliorated aggressiveness in vitro and decreased tumor growth in vivo. Analysis of in silico CLIPseq data in HepG2 cells demonstrated that PRPF8 binds preferentially to exons of protein-coding genes, and RNAseq analysis showed that PRPF8 silencing alters splicing events in multiple genes. Integrated and in vitro analyses revealed that PRPF8 silencing modulates fibronectin (FN1) splicing, promoting the exclusion of exon 40.2, which is paramount for binding to integrins. Consistent with this finding, PRPF8 silencing reduced FAK/AKT phosphorylation and blunted stress fiber formation. Indeed, HepG2 and Hep3B cells exhibited a lower invasive capacity in membranes treated with conditioned medium from PRPF8-silenced cells compared to medium from scramble-treated cells. This study demonstrates that PRPF8 is overexpressed and associated with aggressiveness in HCC and plays important roles in hepatocarcinogenesis by altering FN1 splicing, FAK/AKT activation and stress fiber formation.
Abstract
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role of the spliceosome component PRPF8 (pre-mRNA processing factor 8) in HCC. PRPF8 expression (mRNA/protein) was analyzed in a retrospective cohort of HCC patients (n = 172 HCC and nontumor tissues) and validated in two in silico cohorts (TCGA and CPTAC). PRPF8 expression was silenced in liver cancer cell lines and in xenograft tumors to understand the functional and mechanistic consequences. In silico RNAseq and CLIPseq data were also analyzed. Our results indicate that PRPF8 is overexpressed in HCC and associated with increased tumor aggressiveness (patient survival, etc.), expression of HCC-related splice variants, and modulation of critical genes implicated in cancer-related pathways. PRPF8 silencing ameliorated aggressiveness in vitro and decreased tumor growth in vivo. Analysis of in silico CLIPseq data in HepG2 cells demonstrated that PRPF8 binds preferentially to exons of protein-coding genes, and RNAseq analysis showed that PRPF8 silencing alters splicing events in multiple genes. Integrated and in vitro analyses revealed that PRPF8 silencing modulates fibronectin (FN1) splicing, promoting the exclusion of exon 40.2, which is paramount for binding to integrins. Consistent with this finding, PRPF8 silencing reduced FAK/AKT phosphorylation and blunted stress fiber formation. Indeed, HepG2 and Hep3B cells exhibited a lower invasive capacity in membranes treated with conditioned medium from PRPF8-silenced cells compared to medium from scramble-treated cells. This study demonstrates that PRPF8 is overexpressed and associated with aggressiveness in HCC and plays important roles in hepatocarcinogenesis by altering FN1 splicing, FAK/AKT activation and stress fiber formation.
참고문헌 (40)
- Villanueva, A., "Hepatocellular Carcinoma", N. Engl. J. Med, 380, pp.1450~1462 (2019)
- Forner, A., "Hepatocellular carcinoma", Lancet, 391, pp.1301~1314 (2018)
- Sveen, A., "Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes", Oncogene, 35, pp.2413~2427 (2016)
- Wang, H., "A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine", Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway, 2019, pp.69, 179~195
- Vetter, D., "Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing", Hepatology, 56, pp.1361~1370 (2012)
- Lee, S. E., "Alternative Splicing in Hepatocellular Carcinoma", Cell Mol. Gastroenterol. Hepatol, 10, pp.699~712 (2020)
- Matera, A. G., "A day in the life of the spliceosome", Nat. Rev. Mol. Cell. Biol, 15, pp.108~121 (2014)
- Lopez-Canovas, J. L., "Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma", Cancer Lett, 496, pp.72~83 (2021)
- Kelemen, O., "Function of alternative splicing", Gene, 514, pp.1~30 (2013)
- Fernandez-Espartero, C. H., "Prp8 regulates oncogene-induced hyperplastic growth in Drosophila", Development, 145, pp.dev162156~ (2018)
- Wickramasinghe, V. O., "Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5’ splice site strength", Genome Biol, 16, pp.201~ (2015)
- Kurtovic-Kozaric, A., "PRPF8 defects cause missplicing in myeloid malignancies", Leukemia, 29, pp.126~136 (2015)
- Neelamraju, Y., "Mutational landscape of RNA-binding proteins in human cancers", RNA Biol, 15, pp.115~129 (2018)
- Wang, D., "Splicing Factor Prp8 Interacts With NES(AR)and regulates androgen receptor in prostate cancer cells", Mol. Endocrinol, 29, pp.1731~1742 (2015)
- Wang, S., "Pre-mRNA Processing Factor 8 Accelerates the progression of hepatocellular carcinoma by regulating the PI3K", Akt pathway, 2020, pp.13, 4717~4730
- Gao, Q., "Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma", Cell, 179, pp.561~577 (2019)
- Del Rio-Moreno, M., "Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease", J. Clin. Endocrinol. Metab, 104, pp.3389~3402 (2019)
- Del Rio-Moreno, M., "Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types", Transl. Res, 211, pp.147~160 (2019)
- Guzman-Ruiz, R., "Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals", FASEB J, 34, pp.7520~7539 (2020)
- Rincon-Fernandez, D., "In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines", Carcinogenesis, 39, pp.447~457 (2018)
- Gahete, M. D., "Changes in splicing machinery components influence, precede, and early predict the development of Type 2 diabetes : From the CORDIOPREV Study", EBioMedicine, 37, pp.356~365 (2018)
- Jimenez-Vacas, J. M., "Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer", EBioMedicine, 51, pp.102547~ (2020)
- Duran-Prado, M., "The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells", Oncogene, 31, pp.2049~2061 (2012)
- Fuentes-Fayos, A. C., "Splicing machinery dysregulation drives glioblastoma development", aggressiveness : Oncogenic role of SRSF3, 2020, pp.143, 3273~3293
- Jimenez-Vacas, J. M., "Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer", Transl. Res, 212, pp.89~103 (2019)
- Prinsloo, R. G., "Identifying factors associated with the discharge of male State patients from Weskoppies Hospital", S. Afr. J. Psychiatr, 23, pp.1083~ (2017)
- Zhou, Y., "Fibronectin promotes cervical cancer tumorigenesis through activating FAK signaling pathway", J. Cell Biochem (2019)[DOI]
- Li, W. X., "3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling", Oncotarget, 6, pp.23776~23792 (2015)
- Gillory, L. A., "FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo", Transl. Oncol, 6, pp.206~215 (2013)
- Tavares, S., "Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells", Nat. Commun, 8, pp.15237~ (2017)
- Grainger, R. J., "Prp8 protein: At the heart of the spliceosome", RNA, 11, pp.533~557 (2005)
- McKie, A. B., "Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa(RP13)", Hum. Mol. Genet, 10, pp.1555~1562 (2001)
- Ruzickova, S., "Mutations in spliceosomal proteins and retina degeneration", RNA Biol, 14, pp.544~552 (2017)
- Malz, M., "Transcriptional regulators in hepatocarcinogenesis-key integrators of malignant transformation", J. Hepatol, 57, pp.186~195 (2012)
- Chan, S., "Basal-A triple-negative breast cancer cells selectively rely on RNA splicing for survival", Mol. Cancer Ther, 16, pp.2849~2861 (2017)
- Pankov, R., "Fibronectin at a glance", J. Cell Sci, 115, pp.3861~3863 (2002)
- Morita, Y., "Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma", Clin. Exp. Metastasis, 32, pp.739~753 (2015)
- Cooper, J., "Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance", Cancer Cell, 35, pp.347~367 (2019)
- Cui, X., "Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression", Biochem. Biophys. Res. Commun, 504, pp.784~791 (2018)
- Zhang, Y. Y., "CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway", Cancer Lett, 429, pp.29~40 (2018)